1. Home
  2. BKU vs EVO Comparison

BKU vs EVO Comparison

Compare BKU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$47.86

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.96

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BKU
EVO
Founded
2009
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
778.3M
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
BKU
EVO
Price
$47.86
$1.96
Analyst Decision
Hold
Strong Buy
Analyst Count
12
1
Target Price
$51.58
$7.00
AVG Volume (30 Days)
919.4K
46.9K
Earning Date
04-22-2026
04-08-2026
Dividend Yield
2.87%
N/A
EPS Growth
14.61
N/A
EPS
1.79
N/A
Revenue
$21,732,000.00
N/A
Revenue This Year
$16.26
$1.37
Revenue Next Year
$4.78
$10.05
P/E Ratio
$27.01
N/A
Revenue Growth
7.45
N/A
52 Week Low
$35.10
$1.90
52 Week High
$52.11
$4.27

Technical Indicators

Market Signals
Indicator
BKU
EVO
Relative Strength Index (RSI) 53.20 38.63
Support Level $46.08 $1.90
Resistance Level $48.57 $3.84
Average True Range (ATR) 0.91 0.05
MACD 0.17 0.03
Stochastic Oscillator 78.78 19.67

Price Performance

Historical Comparison
BKU
EVO

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: